ORIC – oric pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) had its price target lowered by analysts at Citigroup Inc. from $15.00 to $14.00. They now have a "buy" rating on the stock.
ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates [Yahoo! Finance]
ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC [Yahoo! Finance]
Form 10-Q Oric Pharmaceuticals, For: Mar 31
Form 8-K Oric Pharmaceuticals, For: May 06
Form ARS Oric Pharmaceuticals, For: Dec 31
Form DEFA14A Oric Pharmaceuticals,
Form DEF 14A Oric Pharmaceuticals, For: Jun 12
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.